Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Evaluation of HbA1c, C-peptide and Rf in DM patients related to COVID-19, ABO group and BMI in Babylon, Iraq

Breadcrumb

  • Home
  • Evaluation of HbA1c, C-peptide and Rf In DM Patients Related To COVID-19, ABO Group and BMI In Babylon, Iraq
  • Evaluation of HbA1c, C-peptide and Rf in DM patients related to COVID-19, ABO group and BMI in Babylon, Iraq

Iman Jaber Hasan 1, karrar salih Mahdi 2, *, Mohammed A. Dabbi 2, Rusul Hamed Obaid 3 and Zainab Mohammed Abass 4

1 Department of Histology and Pathology, College of Veterinary Medicine, Al-Shatrh University, The-Qar ,64007, Iraq.
2 Department of Pathological analysis, College of Science, Al-Qasim Green University, Babylon, 51013, Iraq.
3 Department of medical biotechnology, College of biotechnology, Al-Qasim Green University, Babylon, 51013, Iraq.
4 Department of medical physiology, Hammurabi College of Medicine, university of Babylon, Babylon, 51002, Iraq.
Research Article
GSC Biological and Pharmaceutical Sciences, 2024, 29(01), 265–276.
Article DOI: 10.30574/gscbps.2024.29.1.0398
DOI url: https://doi.org/10.30574/gscbps.2024.29.1.0398
Received on 11 September 2024; revised on 24 October 2024; accepted on 26 October 2024
Background: A total of 30(100%) cases of diabetes mellitus DM were collected from a private laboratory during the period from October 2023 to February 2024, compared with 30 control to evaluate several parameters in a case-control study.
The demographic information of sex distribution for DM cases appear 16 (53%) male and 14(47%) and the mean±SD of the age was 45.6±14.7 compared to the control 33.6±10.5 which reveals a significant at P = 0.0006. The mean±SD of the BMI was 29±6.4 in DM cases compared to the control 25.8±3.4 which reveals a significant difference at P = 0.0187.
Distribution of DM types appears in 16(53%), and 14(47%) cases of DM type 1 and 2 respectively with no significant difference between the two study groups. The mean±SD of HbA1c Level with DM Patients and was 9.2±2.8 compared to the control 5.6±0.9 which appeared a significant at P = 0.0002.
Methods: Evaluation of C-peptide Level appears the mean±SD of the C-peptide for DM cases was 5.7±4.5 compared to the control 3.3±2.4. this case-control study appeared a significant difference at P = 0.0125. RBS Level mean±SD of DM cases was 275.7±121.5 compared to the control 103.7±16.6. this case-control study appeared significant at P = 0.0001. The distribution of DM cases in blood groups O+, A+, B+, AB+, AB-, and O- was 10(33.3%), 8(26.7%), 5(16.7%), 3(10%), 3(10%), 1(3.3%), respectively.
Results: All the cases in the present study show negative results for rheumatoid factor and there is no correlation between RF and DM. 2(7%) DM cases have a cardiac problem while the other 28(93%) don’t suffer from any cardiac problem. Relationship between COVID-19 and DM Type-1 Patients appears 15(50%) have positive COVID-19, 12(40%) has DM type 1 and 3(10%) has DM type-2.
Conclusion: The study was concluded an appositive relationship between age, HbA1c, C-peptide, RBS, O+ and A+ blood groups and developments of diabetes mellitus.
Diabetes; C-peptide; Blood groups; Covid-19
 
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2024-…

Preview Article PDF

Iman Jaber Hasan, karrar salih Mahdi, Mohammed A. Dabbi, Rusul Hamed Obaid and Zainab Mohammed Abass. Evaluation of HbA1c, C-peptide and Rf in DM patients related to COVID-19, ABO group and BMI in Babylon, Iraq. GSC Biological and Pharmaceutical Sciences, 2024, 29(1), 265-276. Article DOI: https://doi.org/10.30574/gscbps.2024.29.1.0398


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution